The impact of Covid-19 extends beyond its effect on physical health; the resulting changes in behavioral patterns and day-to-day functioning, together with tremendous health care and economic impact, is placing significant stress on mental health for people around the world. Data show that large-scale disasters are almost always accompanied by increases in depression, PTSD, substance abuse, and a broad range of other mental and behavioral disorders. It is important to recognize and mitigate the mental health epidemic that will almost certainly follow the Covid-19 pandemic. Watch the above video to witness a panel of mental health, advocacy, and policy experts discuss the actions that must be undertaken to advance prevention-focused mental health care and resilience as we go through and emerge from the Covid-19 pandemic, and the importance of advocacy in mental health.
Speakers:
- Seema Kumar, MS, Vice President of Innovation, Global Health and Policy Communication, Johnson & Johnson Innovation
- Husseini Manji, FRCP (C), MD. Global Therapeutic Area Head, Neuroscience, Johnson & Johnson
- Carlos Sanvee, Secretary General, World YMCA
- Garen Staglin, Chairman, Mental Health Innovation Network
- Michelle Williams, ScD, Dean of the Faculty, Angelopoulos Professor in Public Health and International Development, Harvard T.H. Chan School of Public Health and Harvard Kennedy School